Skip to main content
v2026.11,986 entries · CC-BY 4.0
CASRAIAsk CASRAI · AI assistant for researchAsk a research question. Answers come with their sources.Funder rules, compliance, methods and publishing. Answers link the sources they rest on.

Editorial · CASRAI · AI and ML research outputs

SE3 raises $30 million for spatial AI research

TUM spinout SE3 announced an Accel-led $30 million Series A on November 12, with defence as its immediate market.

Published 16 Nov 2026· 5 minute read

Ask CASRAI · free to try

Ask about this story

2 free questions a day, no account.

An AI assistant for research: funder rules, compliance, methods and publishing. It links the sources behind its answers and labels answers that come from a web search.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays open to read, with no account and no card.

CASRAI is the reference for research administration — bookmark it for the next question.

SE3, a Munich spatial AI company spun out of the Technical University of Munich, announced on November 12, 2026 that it had raised $30 million in Series A funding led by Accel. The financing backs a defence-focused business built from university research, connecting academic commercialisation with questions about the governance of security-relevant AI. SE3 announced the round.

What SE3 announced

Keen Venture Partners, Lakestar and Seedcamp participated alongside Accel. SE3 says it will use the investment to expand its engineering, commercial and operations teams as it scales its business. It identifies European defence as its immediate priority, with a longer-term interest in civilian applications. The announcement concerns investment in the company rather than a university research-grant competition.

Tech Funding News reported the financing on November 12 and said SE3 had not disclosed its valuation or total funding. Fortune independently reported the Accel-led $30 million Series A on November 12. Those reports corroborate the financing event; the company’s descriptions of its technology remain attributed claims.

A software business built from a university lab

Keen’s investment statement identifies the founders as chief executive Lukas Köstler, chief technology officer Simon Klenk and chief science officer Professor Daniel Cremers. It says SE3 spun out of Cremers’ computer vision laboratory at TUM, where Köstler and Klenk were working on their doctorates. That origin places the transaction within university spinout commercialisation: the research connection is the company’s formation and expertise.

Accel describes SE3’s approach as combining computer vision and AI to translate sensor information into spatial understanding. Its investment case centres on software that can integrate with different manufacturers’ hardware. The investor says this gives SE3 a role alongside equipment makers, with European defence as the initial market and robotics and other civilian settings as longer-term possibilities.

For readers following technology transfer, the distinction matters: a laboratory’s methods and expertise can underpin a commercial software supplier whose development priorities are shaped by customers. Accel’s account explicitly links the founders’ academic background to a business serving demanding real-world environments. Its assessment of the team’s commercial prospects is an investor’s judgment.

An earlier partnership provides commercial context

The financing follows a documented industrial relationship. On June 9, 2026, HENSOLDT announced a memorandum of understanding with SE3 Labs at ILA Berlin. The agreement established a framework for strategic cooperation in spatial and agentic AI, including planned integration of SE3 capabilities into HENSOLDT’s MDOcore platform.

HENSOLDT described that integration as future work. The memorandum therefore provides evidence of an announced partnership before the Series A, while its wording distinguishes an agreed cooperation framework from completed integration. For university commercialisation teams, this sequence supplies a concrete example of separate milestones: establishing an industry relationship and subsequently raising growth capital. Neither milestone by itself establishes the performance of every proposed capability.

How the investors explain their backing

In their November 12 statement, Accel’s Matt Robinson and Bodi Tent emphasised the combination of technical expertise, a difficult research problem and customer interest. They presented the financing as another stage in SE3’s commitment to European defence. Their case depends on the opportunity for independent software to work across manufacturers as procurement becomes more modular.

Keen general partner Alexander Ribbink likewise highlighted the combination of research depth and an architecture that hardware manufacturers could adopt. Keen’s statement connects its support to the transition from a university laboratory to commercial use. These are the backers’ reasons for investing, rather than independent evaluations of reliability or a university endorsement of particular applications.

Why research governance is part of the story

The spinout’s academic roots and defence market bring two established institutional responsibilities into the same picture: handling research results and assessing their potential consequences. DFG Guideline 10 on legal and ethical frameworks and usage rights says researchers should evaluate the consequences and ethical aspects of research projects. It also places responsibility on research institutions to establish appropriate organisational structures and procedures.

The guideline addresses documented agreements on the use of data and results, especially where academic and non-academic institutions collaborate. That is relevant background to the distinction between background and foreground intellectual property. In this story, the research-to-company transition makes the allocation of rights a material institutional question; the financing announcement does not establish the terms of any TUM licence or ownership arrangement.

The DFG and Leopoldina Joint Committee’s assessment framework explains how committees for ethics in security-relevant research, known as KEFs, advise researchers. It explicitly includes risks associated with military-related funding and partnerships. Such committees are intended to support case-by-case assessment while respecting scientific freedom.

Its questions cover the purposes pursued by researchers and sponsors, potential risks arising from partners, the expertise needed for an assessment, and whether later reassessment is appropriate. It also considers whether conditions on a project, usage agreements or changes to publication could reduce risks. This supplies a specific research-security context for universities and research offices evaluating related collaborations. These are standing governance considerations, rather than new requirements created by SE3’s fundraising.

What happens next

SE3 says it is opening a UK office, strengthening its presence in Germany and Ukraine, and planning further European expansion. It plans to explore robotics, emergency response and other civilian applications from 2027. Those civilian activities are prospective exploration, not an announcement that a general-purpose research product is available.

The next phase described by the company is therefore organisational growth and continued commercial development, with civilian diversification on a later timetable. For the university research community, the confirmed development is the financing of a research-derived business; the eventual scope of its civilian work remains a company plan.

Sources

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →